Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review

被引:5
作者
Xiang, Yurong [1 ]
Luo, Xiaobin [2 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Med & Life Sci, Chengdu 610000, Sichuan, Peoples R China
[2] Suining Cent Hosp, Dept Resp & Crit Care Med, Suining 629000, Sichuan, Peoples R China
来源
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2024年 / 19卷
关键词
chronic obstructive pulmonary disease; comorbidity; risk factors; therapeutics; GASTROESOPHAGEAL-REFLUX DISEASE; CARDIOVASCULAR-DISEASE; LUNG-FUNCTION; SYSTEMIC INFLAMMATION; ADVERSE OUTCOMES; CLINICAL IMPACT; STATIN USE; COPD; ANEMIA; EXACERBATIONS;
D O I
10.2147/COPD.S447739
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Most patients with chronic obstructive pulmonary disease (COPD) suffer from at least one additional, clinically relevant chronic disease. To a degree, the high global prevalence and mortality rate of COPD is closely related to its extrapulmonary effects. Moreover, the various of comorbidities of COPD and itself interact with each other, resulting in diverse clinical manifestations and individual differences, and thus further influencing the prognosis as well as healthcare burden of COPD patients. This is closely related to the common risk factors of chronic diseases (aging, smoking, inactivity, etc.). Additionally, some pathophysiological mechanisms caused by COPD, including the systemic inflammatory response, hypoxia, oxidative stress, and others, also have an impact on other systems. But comprehensive management and medical interventions have not yet been established. The clinicians should improve their knowledge and skills in diagnosing as well as treating the comorbidities of COPD, and then aim to develop more individualized, efficient diagnostic and therapeutic strategies for different patients to achieve greater clinical benefits. In this article, we will review the risk factors, mechanisms, and treatment strategies for extrapulmonary comorbidities in chronic obstructive pulmonary disease, including cardiovascular diseases, diabetes, anemia, osteoporosis, emotional disorders, and gastroesophageal reflux disease.
引用
收藏
页码:567 / 578
页数:12
相关论文
共 139 条
  • [51] Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease
    Ho, Te-Wei
    Huang, Chun-Ta
    Tsai, Yi-Ju
    Lien, Angela Shin-Yu
    Lai, Feipei
    Yu, Chong-Jen
    [J]. RESPIRATORY RESEARCH, 2019, 20 (1)
  • [52] A systematic review with meta-analysis of gastroesophageal reflux disease and exacerbations of chronic obstructive pulmonary disease
    Huang, Chunrong
    Liu, Yahui
    Shi, Guochao
    [J]. BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [53] The Impact of Depression and Anxiety on Chronic Obstructive Pulmonary Disease Acute Exacerbations: A prospective cohort study
    Huang, Juan
    Bian, Yongjun
    Zhao, Yuanchen
    Jin, Zaiyan
    Liu, Li
    Li, Guangxi
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2021, 281 : 147 - 152
  • [54] Huang Ya-Ling, 2019, Sichuan Da Xue Xue Bao Yi Xue Ban, V50, P88
  • [55] Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids
    Huang, Yi-Jen
    Kao, Senyeong
    Kao, Li-Ting
    Chian, Chih-Feng
    Chung, Chi-Hsiang
    Chien, Wu-Chien
    Wang, Kwua-Yun
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 591 - 602
  • [56] Statin use and exacerbations in individuals with chronic obstructive pulmonary disease
    Ingebrigtsen, Truls S.
    Marott, Jacob L.
    Nordestgaard, Borge G.
    Lange, Peter
    Hallas, Jesper
    Vestbo, Jorgen
    [J]. THORAX, 2015, 70 (01) : 33 - 40
  • [57] Jin Y, 2012, J Clin Pulm Med, V17, P267
  • [58] Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD
    Kang, Jieun
    Lee, Rugyeom
    Lee, Sei Won
    [J]. RESPIRATORY RESEARCH, 2023, 24 (01)
  • [59] Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions
    Kappelmann, N.
    Lewis, G.
    Dantzer, R.
    Jones, P. B.
    Khandaker, G. M.
    [J]. MOLECULAR PSYCHIATRY, 2018, 23 (02) : 335 - 343
  • [60] Endothelial dysfunction in patients with chronic obstructive pulmonary disease in combination with coronary heart disease
    Karoli, N. A.
    Rebrov, A. P.
    [J]. TERAPEVTICHESKII ARKHIV, 2019, 91 (03) : 22 - 26